Study shows stem cell transplant significantly improves outcomes in refractory juvenile systemic sclerosis

by

New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that patients with refractory juvenile systemic sclerosis improved significantly on nearly all measures for two years following autologous stem cell transplant.

Leave A Comment

Your email address will not be published. Required fields are marked *